HUTCHMED (China) (HCM) Income from Non-Controlling Interests (2018 - 2021)
HUTCHMED (China) (HCM) reported Income from Non-Controlling Interests of -$27.6 million for Q4 2021, down 1464.4% quarter-over-quarter from -$1.8 million in Q2 2021.
HUTCHMED (China) (HCM) Income from Non-Controlling Interests (2018 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has 4 years of Income from Non-Controlling Interests data on file, last reported at -$27.6 million in Q4 2021.
- Income from Non-Controlling Interests for Q4 2021 came in at -$27.6 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2021 was -$31.4 million (changed N/A YoY), and the FY2025 annual result was -$105818.5, down 86.54% from the prior year.
- Income from Non-Controlling Interests declined to -$27.6 million in Q4 2021 per HCM's latest filing, from -$1.8 million in the prior quarter.
- Over five years, Income from Non-Controlling Interests peaked at $3.9 million in Q2 2018 and troughed at -$27.6 million in Q4 2021.
- A 4-year average of -$2.4 million and a median of -$715000.0 in 2020 frame the typical range for Income from Non-Controlling Interests.
- The sharpest annual moves came in 2019 and 2020: Income from Non-Controlling Interests soared 158.79% in 2019, then slumped 191.78% in 2020.
- A 4-year view of Income from Non-Controlling Interests shows it stood at $788000.0 in 2018, then slumped by 172.84% to -$574000.0 in 2019, then slipped by 27.7% to -$733000.0 in 2020, then sank by 3671.21% to -$27.6 million in 2021.
- Business Quant data shows HCM's Income from Non-Controlling Interests at -$27.6 million in Q4 2021, -$1.8 million in Q2 2021, and -$1.3 million in Q1 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 22.56 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | HUTCHMED (China) | 1.16 Bn | -306.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -27.64 Mn |
| Jun 30, 2021 | -1.77 Mn |
| Mar 31, 2021 | -1.29 Mn |
| Jun 30, 2020 | -733,000.00 |
| Mar 31, 2020 | -715,000.00 |
| Dec 31, 2019 | -574,000.00 |
| Sep 30, 2019 | 143,000.00 |
| Jun 30, 2019 | -2.69 Mn |
| Mar 31, 2019 | 779,000.00 |
| Dec 31, 2018 | 788,000.00 |
| Sep 30, 2018 | 165,000.00 |
| Jun 30, 2018 | 3.89 Mn |
| Mar 31, 2018 | -1.33 Mn |